Recognising the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva has opened its expanded Shanghai facility. The facility is 11 000 m², fully operational, and designed to help advance and accelerate the development of novel therapeutics.

Customers have access to a wide range of technologies, solutions, and services, including Cytiva’s Fast Trak training centre, a Centre of Excellence for single-use technologies, and a new automation and digital lab. It is also home to China’s online experience centre, customised bioprocess solutions labs and compliance validation labs.

The expanded Fast Trak training centre that can train 2000 people every year, covering the whole biopharma process from process development to commercialisation.

All the updated and expanded functions in the new facility aim to respond to the needs of the fast-evolving biotechnology industry in China, especially in talent training, the adoption of automation and digitalization, and personalised therapies.

The facility includes a new accelerator for novel therapies that uses a biomolecule R&D and GMP pilot manufacturing platform and FlexFactory to facilitate the development and manufacturing of new medicines.